期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
China's aging population:A review of living arrangement,intergenerational support,and wellbeing
1
作者 litao zhao 《Health Care Science》 2023年第5期317-327,共11页
China's rapid population aging and remarkable family-level changes have raised concerns about the weakening of its family-based elderly care.The last decade indeed has seen a clear departure from multigenerational... China's rapid population aging and remarkable family-level changes have raised concerns about the weakening of its family-based elderly care.The last decade indeed has seen a clear departure from multigenerational living to alternative living arrangements such as living with spouse only and solo living.However,ample evidence suggests that Chinese families have demonstrated considerable resilience amidst profound sociodemographic changes.This review article highlights the importance of government–society cooperation in meeting the social challenges of population aging.A key factor is the persistient filial piety norms,which enable children living far or close,migrant or nonmigrant,to rearrange financial,instrumental,and emotional support to aging parents.Equally important is the step-in of the government to share elderly care responsibilities,provide support through deepening pension and healthcare reforms,and implement the active and healthy aging agenda.How the two factors play out over the next decade and beyond will have profound implications on the living arrangement,intergenerational support,and wellbeing of older adults in China. 展开更多
关键词 population aging living arrangement intergenerational support wellbeing filial piety
下载PDF
A review of healthy aging in China,2000-2019
2
作者 litao zhao 《Health Care Science》 2022年第2期111-118,共8页
In 2021,China became an aged society when the share of its elderly population(age 65 years and above)exceeded 14%.In China,as in other upper‐middle‐income and high‐income countries,life expectancy gains are increas... In 2021,China became an aged society when the share of its elderly population(age 65 years and above)exceeded 14%.In China,as in other upper‐middle‐income and high‐income countries,life expectancy gains are increasingly concentrated at older ages with below‐average health and economic activity.Governments worldwide are hence actively pursuing healthy and productive aging.Healthy aging by some measures is taking place.Similar with other upper‐middle‐income countries,China's young old in their 60s are healthier than the same age group two decades ago.The picture is more complex for the older age group(70 years and above).Although there is a substantial decline in leading disease burdens such as stroke and chronic obstructive pulmonary disease,diseases such as Alzheimer's and other dementia are on the rise.To meet the challenge of a rapidly aging population,China's healthy aging agenda should improve its multipronged approach that seeks to promote healthy lifestyles,enhance the healthcare system,create agefriendly communities,and tackle socioeconomic and health disparities. 展开更多
关键词 disability-adjusted life year disease burdens healthy aging life expectancy morbidity
下载PDF
血清/脑脊液中抗LGI1/CASPR2抗体均阳性Morvan综合征1例报道并文献复习 被引量:1
3
作者 赵丽涛 俞英欣 +4 位作者 钱海蓉 姚生 韩晓琛 刘建国 戚晓昆 《中华内科杂志》 CAS CSCD 北大核心 2022年第6期678-681,共4页
本文报道血清及脑脊液富亮氨酸胶质瘤失活蛋白1(LGI1)和接触蛋白相关样蛋白2(CASPR2)抗体四阳性导致的典型Morvan综合征1例患者的临床特点及预后。对该Morvan综合征患者行详细的病史询问和体格检查、多次脑脊液检查、头颅影像学、电生... 本文报道血清及脑脊液富亮氨酸胶质瘤失活蛋白1(LGI1)和接触蛋白相关样蛋白2(CASPR2)抗体四阳性导致的典型Morvan综合征1例患者的临床特点及预后。对该Morvan综合征患者行详细的病史询问和体格检查、多次脑脊液检查、头颅影像学、电生理检查以及预后进行分析。临床特点:患者青年女性, 39岁, 首发症状表现为四肢无力, 病程中主要症候包括发作性肢体疼痛、憋喘、瘙痒、肌颤搐、癫痫、记忆力减退、烦躁、淡漠、顽固性失眠、流涎、出汗异常。实验室检查:电解质示低钾血症(2.7~3.1 mmol/L)、低钠血症(130~136 mmol/L);血气分析示低氧血症(氧分压50%~70%)。甲状腺功能:总甲状腺腺素(TT4)207 nmol/L、甲状腺过氧化物酶抗体(TPO-Ab)15.3 IU/ml、甲状腺球蛋白抗体(TG-Ab)16.9 IU/ml;血清和脑脊液抗LGI1/CASPR2抗体呈四阳性, 其他自身免疫相关脑炎及副肿瘤综合征相关抗体均阴性。头颅MRI未见异常;脑电图轻度异常;肌电图示左股四头肌运动单位电位电压略高。治疗及预后:激素+丙种球蛋白+吗替麦考酚酯片联合治疗, 患者临床症状完全缓解。治疗前后认知功能评分:治疗前蒙特利尔认知评估量表(MoCA)/简易智力状态检查(MMSE)(16分/24分)、治疗后MoCA/MMSE(26分/29分)。Morvan综合征血清/脑脊液中LGI1/CASPR2抗体四阳性罕见, 但临床症候典型, 尽早免疫治疗效果显著。 展开更多
关键词 Morvan综合征 脑炎 自身免疫性 富亮氨酸胶质瘤失活蛋白1 接触蛋白相关样蛋白2
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部